UY

Updesh Yadav

Director Director DIN 07107522
DIN 07107522 First appointment Mar 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2015
Shareholding value Locked Premium profile

About Updesh Yadav

Data last updated:

Updesh Yadav has 11 years in corporate governance. Formerly with 1 company, such as Biogenetic Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07107522
Primary Designation Director
First Appointment 31 Mar 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Biogenetic Drugs Private Limited U24232RJ2004PTC018909
Director31 Mar 20152004Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biogenetic Drugs Private Limited
Premium access

Shareholding and investment profile for Updesh Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Updesh Yadav

Updesh Yadav has 11 years in corporate governance. Formerly with 1 company, such as Biogenetic Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Updesh Yadav is associated with 0 companies as a director.

Updesh Yadav has expertise in General Business.

Updesh Yadav has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available